U.S. Water Utilities Stock News

American Water Works Company (AWK) shares have been moving modestly in recent sessions, catching the attention of investors interested in steady utility stocks. Over the past month, the stock has declined about 6% as a result of broader sector fluctuations. See our latest analysis for American Water Works Company. AWK’s recent share price dip fits into a year of muted momentum for the utility sector, with the 1-year total shareholder return at -0.95% despite some brief upticks. At the same...

Ever wondered if now is the moment to scoop up Adobe stock, or if it is still trading at a premium? You are not alone in asking whether the current price offers real value or not. Shares have dipped 8.3% over the past month and are down 26.5% year-to-date, which could catch the eye of bargain hunters or those concerned about shifting risks. Recently, headlines have focused on Adobe's bold investments in artificial intelligence and ongoing product innovation. These moves have sparked both...

West Pharmaceutical Services (WST) saw its stock surge after delivering third-quarter earnings that topped expectations, with management lifting the company’s full-year financial guidance. The strong results reflected ongoing organic growth and operational momentum. See our latest analysis for West Pharmaceutical Services. West Pharmaceutical Services’ momentum has picked up steam after its recent earnings beat and upgraded guidance, with the shares jumping 5.2% in the latest session and...

Earlier this week, Citi analyst Craig Mailman downgraded Tanger Factory Outlet Centers Inc., reflecting a more reserved outlook for the company's near-term prospects. This adjustment by a well-followed analyst underscores how shifts in market sentiment can quickly shape institutional positioning and investor perception. We'll examine how this recent analyst downgrade could reshape Tanger's investment narrative given heightened attention on rental income stability and sector outlook. We've...

TE Connectivity (TEL) recently held its Investor Day in Philadelphia, providing a detailed roadmap of growth initiatives and operational targets. Management outlined plans for cycle-resilient revenue growth and higher margins, which has sparked renewed attention on the stock. See our latest analysis for TE Connectivity. Momentum around TE Connectivity has picked up following its recent Investor Day, where strong growth targets and a focus on margins created renewed optimism. The stock has...

Wondering if JPMorgan Chase is trading at a fair price or if there may be hidden value? You are not alone. Even seasoned investors are looking for answers with the stock near all-time highs. After a year-to-date surge of 24.2% and a five-year return of 179.9%, JPMorgan Chase has recently pulled back slightly. The last week and month returns are -1.8% and -0.8% respectively. Recent headlines have highlighted JPMorgan Chase's strategy to expand its digital banking footprint and its initiatives...

ICU Medical (ICUI) shares have gained over 15% over the past month, catching investors’ attention as they track healthcare sector moves. The company’s recent performance offers a telling look at shifting sentiment surrounding its business. See our latest analysis for ICU Medical. The rebound in ICU Medical’s share price, up over 15% in the last month and now trading at $142.34, stands out especially after a tough stretch. Even with this surge, the 1-year total shareholder return remains...

ePlus (PLUS) shares have seen some movement lately, with the stock climbing nearly 24% over the past month. Investors are watching to see whether this momentum will continue as market sentiment shifts. See our latest analysis for ePlus. Over the past several months, ePlus has seen strong momentum, with its 1-month share price return of 23% helping lift the stock to $91.51. Despite some recent volatility, the past year’s total shareholder return of 11% reflects steady progress for longer-term...

PennyMac Mortgage Investment Trust recently reported strong third-quarter earnings, with its CEO purchasing additional shares and maintaining a long history of dividend payments. An interesting aspect is that these developments were supported by optimism over possible Federal Reserve rate cuts, which tend to benefit mortgage REITs and contributed to a boost in investor confidence. We’ll explore how renewed expectations for interest rate cuts, highlighted by recent insider buying and firm...

Natera (NTRA) has been making waves following its strong third quarter, with year-over-year sales of the company’s Signatera test jumping 78%. The recent integration of Natera’s oncology portfolio into Flatiron Health’s OncoEMR platform also stands out as an important move. This integration makes test ordering more seamless for thousands of U.S. cancer care providers. See our latest analysis for Natera. Natera’s recent moves have sparked a surge in momentum, with a 41.95% share price return...

Danaher Corporation reported a 10.5% year-over-year increase in third-quarter 2025 adjusted earnings and participated in the Jefferies London Healthcare Conference on November 18, 2025, with CEO Rainer M. Blair presenting. Despite the strong quarterly results, the company’s guidance for low single-digit adjusted core sales growth and recent downward analyst estimate revisions highlight ongoing market caution about near-term performance. We'll explore how Danaher's strong third-quarter...

Freedom Capital Markets has just initiated coverage on Playtika Holding (PLTK), stirring interest as the company reported a year-over-year dip in total revenue. However, there was notable growth in Direct-to-Consumer sales and daily paying users. See our latest analysis for Playtika Holding. It has been a tough twelve months for Playtika’s investors, with the stock’s year-to-date share price return sitting at -45%, and a 1-year total shareholder return of -52%. These results reflect the...

Prologis (PLD) has drawn attention from investors this week as its stock performance shows some interesting patterns compared to the broader market. The recent movement prompts a closer look at how the company is navigating the economic environment. See our latest analysis for Prologis. After a solid run in recent months, Prologis is showing renewed momentum, with a 90-day share price return of 12.69%. Over the last year, the total shareholder return stands at 12.60%, a pace that has...

Teradyne, Inc. recently announced a quarterly cash dividend of $0.12 per share, payable on December 17, 2025, to shareholders of record as of November 24, 2025. While Teradyne's dividend declaration was routine, recent trading shows large investors expressing increased caution through a sharp rise in put option activity. We'll examine how renewed bearish sentiment among institutional investors could influence Teradyne's investment narrative moving forward. We've found 16 US stocks that are...

In November 2025, Canadian Solar Inc. reported third quarter earnings, returning to net profitability with net income of US$8.99 million and revenue of US$1.49 billion, and issued revenue guidance for fourth quarter 2025 in the range of US$1.3 billion to US$1.5 billion. The shift to net profitability this quarter, following a net loss the previous year, marks a noteworthy turnaround and provides new insight into the company’s operational performance. We’ll examine how Canadian Solar’s...

AT&T recently announced the rapid nationwide deployment of mid-band spectrum acquired from EchoStar, enhancing 5G download speeds across more than 5,300 cities and 23,000 cell sites in the United States. This large-scale activation not only reinforces EchoStar's successful spectrum commercialization but also highlights its expanding role in enabling advanced U.S. telecommunications infrastructure. We'll take a look at how EchoStar's spectrum sale to AT&T reshapes its investment narrative and...

Eastman Chemical (EMN) shares have drifted lower over the past month, with the stock trading down around 5%. Despite the muted price action recently, the company’s fundamentals and long-term positioning remain worth watching. See our latest analysis for Eastman Chemical. Eastman Chemical’s share price has had a rough time lately, continuing a downtrend that has lasted most of this year. While the stock rebounded 5.6% in a single day recently, its year-to-date share price return is a steep...

On November 18, 2025, the California Public Utilities Commission approved American States Water Company’s request to defer the cost of capital application for its subsidiary, Golden State Water Company, by one year, keeping in place the current Water Cost of Capital Mechanism and a 7.93% authorized rate of return through December 31, 2027. This extension ensures regulatory stability for the company, allowing for more predictable financial planning at a time when investor concerns about rate...

In the past quarter, Mondelez International faced input cost pressures as cocoa futures prices surged, driven by challenging crop yield conditions in West Africa, a major supplier for the company. In response, Mondelez has sought to diversify its cocoa sourcing by expanding into Southeast Asia, aiming to reduce risk from regional supply disruptions. We'll examine how the impact of ongoing cocoa cost inflation could alter Mondelez International's longer-term investment narrative and margin...

Webull (BULL) is getting extra attention after its quarterly earnings update showed a big jump in revenue and a swing from loss to profit. The recent launch of its advanced AI tool, Vega, is also generating discussion among investors. See our latest analysis for Webull. After unveiling both a sharp increase in revenue and its new Vega platform, Webull has seen momentum shift rapidly. While investor excitement followed those headlines, the stock’s 1-year total shareholder return is still down...

Nuvalent caught the market’s attention after the U.S. FDA accepted its New Drug Application for zidesamtinib, a potential treatment for adults with advanced ROS1-positive non-small cell lung cancer who have previously been treated with tyrosine kinase inhibitors. See our latest analysis for Nuvalent. After the FDA’s acceptance of Nuvalent’s New Drug Application and a series of upbeat trial results, the share price has rallied, jumping 13.4% over the past month and surging 43% over the last 90...

PPG Industries (PPG) has seen some movement in its stock lately, with shares currently at $98.70. Over the past month and the past three months, the stock is down roughly 5 percent and 12 percent respectively, reflecting recent market sentiment. See our latest analysis for PPG Industries. Despite a solid start to the year, momentum for PPG Industries has faded lately, with the share price at $98.70 and the year-to-date share price return at -14.5%. When taking dividends into account, the...

Oracle (ORCL) recently made headlines after unveiling a $30 billion annual cloud services contract. This move underscores its ambition in AI and cloud infrastructure. The company’s strategic shift, along with major data center investments, is drawing extra investor scrutiny. See our latest analysis for Oracle. Recent headlines have only amplified the spotlight on Oracle’s cloud ambitions, but the past few months have been rocky for its share price. After a surge tied to AI-driven optimism,...

In late October 2025, Alkami Technology reported third-quarter financial results that fell short of consensus estimates for both earnings per share and revenue, and Pomerantz LLP began investigating potential securities fraud by the company and its leadership. Amid these challenges, a separate announcement highlighted a new partnership between Spiral and Alkami to add advanced savings and giving tools to Alkami's digital banking platform, with rapid early user adoption. We'll explore how...